Field Trip Psychedelics Inc.

The Analyst Analyst Pablo Zuanic from Cantor Fitzgerald kept an Overweight rating for Irwin Naturals (CSE: IWIN) (OTC: IWINF) but lowered its 12-month price target to US$6.00 (C$8.05) from US$6.20 “on adjusted estimates.” The Thesis Zuanic highlighted the “potential approval...

Field Trip Psychedelics Inc. announced Tuesday the successful synthesis of FT-104, a novel compound that is believed to have psychedelic capabilities. The conclusion comes after in-vitro and in-vivo tests confirmed that FT-104 interacts with the 5HT2A receptor, which is the main antagonist targeted...

Compass Pathways Files for an IPO at NASDAQ UK-based Compass Pathways wants to become the first psychedelics company to list on a major U.S. stock exchange. The psilocybin research company intends to make its initial public offering (IPO) through NASDAQ under the ticker symbol...